Results 171 to 180 of about 227,154 (335)

Treatment of Recurrent Erythema Nodosum Leprosum with Infliximab [PDF]

open access: bronze, 2006
William R. Faber   +2 more
openalex   +1 more source

Erythema Multiforme

open access: yesInternational Journal of Clinical Practice, 1955
openaire   +2 more sources

Premycotic Erythema [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1938
openaire   +2 more sources

Peri‐implant hypoxia as a potential barrier against ferroptotic mechanisms during peri‐implant diseases: A cross‐sectional study

open access: yesJournal of Periodontology, EarlyView.
Abstract Background Hypoxia modulates inflammation and oxidative stress through hypoxia‐inducible factor‐1α (HIF‐1α). Ferroptosis, an iron‐dependent cell death process, is regulated by glutathione peroxidase‐4 (GPX4) and involves lipid peroxidation markers like malondialdehyde (MDA).
Büşra Yılmaz   +5 more
wiley   +1 more source

Lepromatous Leprosy with Erythema Nodosum Leprosum Masquerading as Quadriparesis

open access: diamond, 2021
Arushi Gakhar   +4 more
openalex   +1 more source

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Extraintestinal manifestations (EIMs) manifest in 6%‐47% of patients with inflammatory bowel disease (IBD). Here, we characterize the course of EIMs in pediatric patients receiving vedolizumab included in the VedoKids cohort study. This was a subgroup analysis of the pediatric VedoKids cohort, a multicenter, prospective study of children (aged
Giulia D'Arcangelo   +11 more
wiley   +1 more source

ERYTHEMA INDURATUM OF BAZIN MIMICKING POLYARTERITIS NODOSA CASE REPORT

open access: gold, 2023
João Pedro Miranda Pesca   +9 more
openalex   +1 more source

Erythema necroticans [PDF]

open access: yesQJM: An International Journal of Medicine, 2019
A Panigrahi, A Sil, D B Bhanja
openaire   +2 more sources

Home - About - Disclaimer - Privacy